Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes

Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clin...

Full description

Saved in:
Bibliographic Details
Published in:American journal of infection control 2014-02, Vol.42 (2), p.206-208
Main Authors: Özgür, Eylem Sercan, MD, Horasan, Elif Sahin, MD, Karaca, Kerem, MD, Ersöz, Gülden, MD, Naycı Atış, Sibel, MD, Kaya, Ali, MD
Format: Article
Language:English
Subjects:
Acinetobacter baumannii
Acinetobacter baumannii - drug effects
Acinetobacter baumannii - isolation & purification
Acinetobacter Infections - epidemiology
Acinetobacter Infections - microbiology
Acinetobacter Infections - mortality
Acinetobacter Infections - pathology
Adult
Aged
Bacteria
Biological and medical sciences
Cohort Studies
Comparative analysis
Drug resistance
Drug Resistance, Multiple, Bacterial
Epidemiology. Vaccinations
Female
General aspects
Human infectious diseases. Experimental studies and models
Humans
Infection Control
Infectious Disease
Infectious diseases
Length of Stay
Male
Medical sciences
Middle Aged
Mortality
Outcome
Pneumology
Pneumonia
Pneumonia, Ventilator-Associated - epidemiology
Pneumonia, Ventilator-Associated - microbiology
Pneumonia, Ventilator-Associated - mortality
Pneumonia, Ventilator-Associated - pathology
Respiratory system : syndromes and miscellaneous diseases
Retrospective Studies
Risk Factors
SAPS II
Simplified Acute Physiology Score II
Survival Analysis
Treatment Outcome
Ventilator-associated pneumonia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.
ISSN:0196-6553
1527-3296
DOI:10.1016/j.ajic.2013.09.003